The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
India’s pharmaceutical sector stands at a pivotal inflection point
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Subscribe To Our Newsletter & Stay Updated
